Try our Advanced Search for more refined results

September 04, 2020

FRESENIUS KABI DEUTSCHLAND GMBH et al v. GLAND PHARMA LIMITED

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 08, 2020

    Fresenius Accuses Rival Of Infringing Naropin Patent

    Fresenius Kabi has accused Gland Pharma Ltd. of infringing a patent covering the pain management drug Naropin by trying to get U.S. Food and Drug Administration approval to sell a generic version of the medication.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login